Clobazam

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 31722-641
  • Package NDC 31722-641-12
  • Application number ANDA209796
  • SPL ID 556132d3-7f61-e679-e063-6394a90a4528
  • SPL set ID c9b51794-3cfa-4a34-b5bb-d523b5798c17
  • UNII 2MRO291B4U
  • RxCUI 1366192

What the source publishes

Labeler
Camber Pharmaceuticals, Inc.
Active ingredients
Clobazam
Form
SUSPENSION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:31722-641_556132d3-7f61-e679-e063-6394a90a4528
{
  "name": "Clobazam",
  "splId": "556132d3-7f61-e679-e063-6394a90a4528",
  "labels": [
    {
      "setId": "c9b51794-3cfa-4a34-b5bb-d523b5798c17",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c9b51794-3cfa-4a34-b5bb-d523b5798c17",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c9b51794-3cfa-4a34-b5bb-d523b5798c17"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Camber Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BOTTLE, GLASS in 1 CARTON (31722-641-12)  / 120 mL in 1 BOTTLE, GLASS",
      "package_ndc": "31722-641-12",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200224"
    }
  ],
  "productId": "31722-641_556132d3-7f61-e679-e063-6394a90a4528",
  "useDomain": "unknown",
  "dosageForm": "SUSPENSION",
  "productNdc": "31722-641",
  "deaSchedule": "CIV",
  "genericName": "Clobazam",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CLOBAZAM",
      "strength": "2.5 mg/mL"
    }
  ],
  "applicationNumber": "ANDA209796",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20200224",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175694",
      "M0002356",
      "N0000182137",
      "N0000185506"
    ],
    "upc": [
      "0331722641128"
    ],
    "unii": [
      "2MRO291B4U"
    ],
    "rxcui": [
      "1366192"
    ],
    "spl_set_id": [
      "c9b51794-3cfa-4a34-b5bb-d523b5798c17"
    ],
    "pharm_class_cs": [
      "Benzodiazepines [CS]"
    ],
    "pharm_class_epc": [
      "Benzodiazepine [EPC]"
    ],
    "pharm_class_moa": [
      "Cytochrome P450 2D6 Inhibitors [MoA]",
      "Cytochrome P450 3A4 Inducers [MoA]"
    ],
    "manufacturer_name": [
      "Camber Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:31722-641_556132d3-7f61-e679-e063-6394a90a4528"